Publications

Discontinuation of Tyrosine Kinase Inhibitors in Cml Patients in Real-World Clinical Practice at a Single Institution

AuthID
P-00Q-0DZ

Author(s)

Cerveira, N

Loureiro, B

Bizarro, S

Correia, C

Torres, L

Lisboa, S

Vieira, J

Santos, R

Pereira, D

Moreira, C

Chacim, S

Domingues, N

Espirito Santo, A

Oliveira, I

Moreira, I

Viterbo, L

Martins, A

Teixeira, MR

Mariz, JM

Document Type

Article

Year published

2018

Published

in BMC CANCER, ISSN: 1471-2407

Volume: 18, Issue: 1

Indexing

Wos^®

Scopus^®

Crossref^®14

Pubmed^®

Google Scholar^®

Metadata
Sources

Publication Identifiers

DOI: 10.1186/s12885-018-5167-y

Pubmed: 30541488

Scopus: 2-s2.0-85058592413

Wos: WOS:000452959400004

Source Identifiers

ISSN: 1471-2407

Export Publication Metadata

Marked List

Add to Marked List

Info

At this moment we don't have any links to full text documens.

Discontinuation of Tyrosine Kinase Inhibitors in Cml Patients in Real-World Clinical Practice at a Single Institution

Useful Links

Get Help

Federated Authentication (Click on the image)

Discontinuation of Tyrosine Kinase Inhibitors in Cml Patients in Real-World Clinical Practice at a Single Institution

Useful Links

Get Help